| 17/06/26 | 14:32:46 | 17 Jun 2026 | | Result of AGM |
| 22/05/26 | 12:38:58 | 22 May 2026 | | Posting of Annual Report and Notice of AGM |
| 21/05/26 | 07:00:09 | 21 May 2026 | | AMR Bio: Commercial Update |
| 19/05/26 | 07:01:01 | 19 May 2026 | | Final Results for the year ended 31 December 2025 |
| 19/05/26 | 07:00:04 | 19 May 2026 | | Phantom Carried Interest Scheme |
| 14/05/26 | 07:00:07 | 14 May 2026 | | Notice of Final Results |
| 24/02/26 | 12:38:28 | 24 Feb 2026 | | TR-1 |
| 12/02/26 | 07:00:09 | 12 Feb 2026 | | Portfolio Update |
| 02/02/26 | 07:00:07 | 2 Feb 2026 | | Trading and Portfolio Update |
| 08/01/26 | 07:00:08 | 8 Jan 2026 | | PDMR Dealing |
| 23/12/25 | 07:00:07 | 23 Dec 2025 | | Sofant Technologies: Fundraising |
| 19/12/25 | 07:00:01 | 19 Dec 2025 | | Director/PDMR Dealing |
| 10/12/25 | 07:00:09 | 10 Dec 2025 | | Wanda Health: Fundraising and Business Update |
| 08/12/25 | 07:00:11 | 8 Dec 2025 | | Share Issue, PDMR Dealings & Total Voting Rights |
| 04/12/25 | 07:00:01 | 4 Dec 2025 | | TR-1 |
| 24/11/25 | 07:00:11 | 24 Nov 2025 | | Expansion of Senior Finance Leadership Team |
| 20/11/25 | 07:00:15 | 20 Nov 2025 | | Portfolio Update |
| 30/09/25 | 07:00:11 | 30 Sept 2025 | | Interim Results and Investor Presentation |
| 22/09/25 | 07:00:12 | 22 Sept 2025 | | Asset Purchase Agreement with Destiny Pharma |
| 18/09/25 | 07:00:13 | 18 Sept 2025 | | Notice of Interim Results |
| 30/06/25 | 12:22:30 | 30 Jun 2025 | | Result of AGM |
| 30/06/25 | 07:00:03 | 30 Jun 2025 | | Office move and Related Party Transaction |
| 27/06/25 | 07:00:08 | 27 Jun 2025 | | Q-Bot Limited Fundraising |
| 10/06/25 | 13:28:40 | 10 Jun 2025 | | TR-1 |
| 06/06/25 | 15:12:12 | 6 Jun 2025 | | Notice of AGM and Annual Report & Accounts |
| 04/06/25 | 14:34:35 | 4 Jun 2025 | | Director/PDMR Shareholding |
| 04/06/25 | 07:00:10 | 4 Jun 2025 | | Preliminary results for the year ended 31 Dec 2024 |
| 14/05/25 | 16:02:50 | 14 May 2025 | | PDS: Q1 Results and Clinical and Corporate Update |
| 09/05/25 | 10:30:58 | 9 May 2025 | | TR-1 |
| 27/03/25 | 16:46:02 | 27 Mar 2025 | | PDS: Q4 Results and Clinical Programs Update |
| 07/03/25 | 16:26:27 | 7 Mar 2025 | | PDS: VERSATILE-003 Phase 3 Clinical Trial |
| 27/02/25 | 16:30:26 | 27 Feb 2025 | | PDS: up to $22mn Registered Direct Offering |
| 05/02/25 | 15:24:50 | 5 Feb 2025 | | PDS Biotech reaffirms guidance for clinical trial |
| 03/02/25 | 07:00:06 | 3 Feb 2025 | | ProAxsis: Status Update and Proposed Fundraise |
| 06/01/25 | 16:42:57 | 6 Jan 2025 | | TR-1 |
| 31/12/24 | 07:05:00 | 31 Dec 2024 | | Grant of Share Options |
| 31/12/24 | 07:00:05 | 31 Dec 2024 | | Q-Bot Fundraising |
| 12/12/24 | 16:49:51 | 12 Dec 2024 | | TR-1 |
| 09/12/24 | 07:00:06 | 9 Dec 2024 | | Wanda Health Fundraising |
| 05/12/24 | 07:00:20 | 5 Dec 2024 | | Close of Fundraising and Result of Retail Offer |
| 03/12/24 | 13:24:09 | 3 Dec 2024 | | Result of Subscription |
| 03/12/24 | 07:05:01 | 3 Dec 2024 | | WRAP Retail Offer |
| 03/12/24 | 07:00:07 | 3 Dec 2024 | | Proposed Subscription and Retail Offer; Update |
| 14/11/24 | 15:59:35 | 14 Nov 2024 | | Replacement RNS: PDS: Update, 3rd Quarter Results |
| 14/11/24 | 15:23:11 | 14 Nov 2024 | | PDS: Clinical Programs Update, 3rd Quarter Results |
| 08/10/24 | 07:00:07 | 8 Oct 2024 | | Director/PDMR Shareholding |
| 03/10/24 | 07:00:06 | 3 Oct 2024 | | Director/PDMR Shareholding |
| 02/10/24 | 16:38:29 | 2 Oct 2024 | | PDS: 36-Month Overall Survival Rate announcement |
| 30/09/24 | 07:00:09 | 30 Sept 2024 | | Interim Results |
| 26/09/24 | 07:00:15 | 26 Sept 2024 | | Name change and AIM Rule 26 website |
